Filing Details
- Accession Number:
- 0001104659-22-010336
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-01 16:30:39
- Reporting Period:
- 2022-01-28
- Accepted Time:
- 2022-02-01 16:30:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1633070 | Axcella Health Inc. | AXLA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1774662 | William Hinshaw | C/O Axcella Health Inc. 840 Memorial Drive Cambridge MA 02139 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-01-28 | 50,000 | $0.00 | 50,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-01-31 | 16,590 | $1.65 | 33,410 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2022-01-28 | 50,000 | $0.00 | 50,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of AXLA common stock.
- Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.61 to $1.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The restricted stock units vested in full on January 28, 2022.